Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROCEPT AQUABEAM Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

NCT03167294 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.

NCT NCT03167294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03167294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROCEPT AQUABEAM Study for the Treatment of Benign Prostatic Hyperplasia (ABS)
Lead sponsor
PROCEPT BioRobotics
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2014
Completion date
April 27, 2017
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia